Table 1.
Variables |
Wii
(n=8) N (%) or Mean (SD) |
EXCAP
(n=6) N (%) or Mean (SD) |
Control
(n=5) N (%) or Mean (SD) |
p-value |
---|---|---|---|---|
Demographics | ||||
Age | 77.5 (6.7) | 75.7 (9.5) | 71.8 (5) | 0.41 |
Range | 70-87 | 67-93 | 67-80 | |
Marital Status | ||||
Married | 6 (75.0) | 3 (50.0) | 4 (80.0) | 0.49 |
Unmarried | 2 (25.0) | 3 (50.0) | 1 (20.0) | |
Education | ||||
HS/Some | ||||
college | 6 (75.0) | 3 (50.0) | 2 (40.0) | 0.41 |
Bachelors+ | 2 (25.0) | 3 (50.0) | 3 (60.0) | |
Work | ||||
Working | 3 (37.5) | 4 (66.7) | 1 (20.0) | 0.28 |
Not working | 5 (62.5) | 2 (33.3) | 4 (80.0) | |
Race | ||||
White | 7 (87.5) | 4 (66.7) | 3 (60.0) | 0.49 |
African | ||||
American | 1 (12.5) | 2 (33.3) | 2 (40.0) | |
| ||||
Clinical
characteristics |
||||
BMI | 29.5 (4.2) | 28.5 (3.5) | 31.8 (4.7) | 0.43 |
IADL | 11.1 (1.7) | 11.8 (0.4) | 11.4 (0.5) | 0.56 |
KPS | 87.5 (8.9) | 88.3 (13.3) | 88 (16.4) | 0.99 |
Time on ADT (months) | 67.4 (67.9) | 58.7 (56.3) | 60 (66.6) | 0.96 |
Gleason Score | 7.1 (1.6) | 8.0 (1) | 7.6 (1.3) | 0.54 |
PSA | 1.9 (2.9) | 2.4 (3.1) | 21.9 (30.2) | 0.09 |
Comorbidity | ||||
0 to 1 | 6 (75.0) | 4 (66.7) | 3 (60.0) | 0.96 |
2 | 2 (25.0) | 2 (33.3) | 2 (40.0) | |
Outcomes | ||||
SPPB | 9.1 (2.0) | 8.7 (2.8) | 7.8 (3.4) | 0.69 |
Handgrip | 29.1 (6.2) | 33.8 (11.0) | 34.7 (6.8) | 0.41 |
Steps per day | 2999.9 (2627.9) | 3593.9 (2777.1) | 2625.7 (2286.1) | 0.82 |
Muscle Mass | 49 (6.2) | 56.3 (6.8) | 59.4 (8.2) | 0.04 |
Chest press repetition max |
59.1 (12.2) | 78.8 (29.1) | 72 (19.2) | 0.22 |
Abbreviations: BMI – Body Mass Index, IADL – instrumental activities of daily living, KPS – Karnofsky Performance Status, ADT – Androgen deprivation therapy, PSA – Prostate-specific antigen, SPPB –Short physical performance battery P-values represent comparisons of covariates across study arms using ANOVA or Pearson Chi-Square tests
* Two individuals with high PSA were in the control arm with values of 44.8 and 63.5